Sodium(1R,4S,5R)-1,4,5-Trihydroxy-3-(5-methylbenzo[b]-thiophen-2-yl)methoxycyclohexan-1-carboxylate

ID: ALA567564

PubChem CID: 44627427

Max Phase: Preclinical

Molecular Formula: C17H17NaO6S

Molecular Weight: 350.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc2sc(COC3=C[C@@](O)(C(=O)[O-])C[C@@H](O)[C@@H]3O)cc2c1.[Na+]

Standard InChI:  InChI=1S/C17H18O6S.Na/c1-9-2-3-14-10(4-9)5-11(24-14)8-23-13-7-17(22,16(20)21)6-12(18)15(13)19;/h2-5,7,12,15,18-19,22H,6,8H2,1H3,(H,20,21);/q;+1/p-1/t12-,15+,17-;/m1./s1

Standard InChI Key:  QDNKFBLMZXFZAX-NQLNPJAESA-M

Molfile:  

     RDKit          2D

 25 26  0  0  0  0  0  0  0  0999 V2000
    4.2397   -2.7806    0.0000 Na  0  0  0  0  0 15  0  0  0  0  0  0
   11.2016   -4.7608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2016   -5.5862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9141   -5.9948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6264   -5.5862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6264   -4.7608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9141   -4.3439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4934   -3.6269    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.3189   -3.6269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1443   -3.6190    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.8993   -2.9160    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.9141   -6.8202    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4874   -6.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3406   -6.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7719   -5.5883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0577   -6.0020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3025   -5.6658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9719   -6.8214    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.1648   -6.9943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7562   -6.2813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9362   -6.2797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5240   -6.9904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9377   -7.7042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7562   -7.7023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6985   -6.9902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3 13  1  0
  5  6  1  0
  5 14  1  1
  6  7  1  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
  7  8  1  6
 17 20  1  0
 19 18  1  0
 18 16  1  0
  7  9  1  0
  2  3  2  0
 19 20  2  0
  9 10  1  0
 20 21  1  0
  2  7  1  0
 21 22  2  0
  9 11  2  0
 22 23  1  0
  3  4  1  0
 23 24  2  0
 24 19  1  0
  4 12  1  6
 22 25  1  0
  4  5  1  0
M  CHG  2   1   1  10  -1
M  END

Associated Targets(non-human)

aroQ 3-dehydroquinate dehydratase (50 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
aroQ 3-dehydroquinate dehydratase (62 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 350.39Molecular Weight (Monoisotopic): 350.0824AlogP: 1.55#Rotatable Bonds: 4
Polar Surface Area: 107.22Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 3.99CX Basic pKa: CX LogP: 1.09CX LogD: -2.07
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.67Np Likeness Score: 0.16

References

1. Prazeres VF, Tizón L, Otero JM, Guardado-Calvo P, Llamas-Saiz AL, van Raaij MJ, Castedo L, Lamb H, Hawkins AR, González-Bello C..  (2010)  Synthesis and biological evaluation of new nanomolar competitive inhibitors of Helicobacter pylori type II dehydroquinase. Structural details of the role of the aromatic moieties with essential residues.,  53  (1): [PMID:19911771] [10.1021/jm9010466]
2. Tizón L, Otero JM, Prazeres VF, Llamas-Saiz AL, Fox GC, van Raaij MJ, Lamb H, Hawkins AR, Ainsa JA, Castedo L, González-Bello C..  (2011)  A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors.,  54  (17): [PMID:21780742] [10.1021/jm2006063]

Source